News

Implications of Recent EU and UK Court Decisions in the Pharmaceutical Sector

Thursday, September 27, 2018

Registration
5:45 pm

Seminar
6:00 pm

Networking drinks and canapés
7:00 pm

Arnold & Porter
Tower 42 25 Old Broad Street
London
EC2N 1HQ
United Kingdom

Emily MacKenzie, Barrister at Brick Court Chambers, will join Libby Amos of Arnold & Porter's Future Pharma Forum to recap how challenges to pharmaceutical decisions may be brought to the European and domestic courts. Emily will provide a summary of recent European Court and English Court decisions in the pharmaceutical area, and together Libby and Emily will explore the implications for pharmaceutical companies.

Topics

  • How to bring challenges to the European Court.
  • The interplay of domestic proceedings.
  • Summary of recent European Court decisions, including:
      • Shire on orphan market exclusivity, and
      • Astellas on the role of the Concerned Member State.
  • Summary of recent English Court decisions, including Napp on the Article 10(3) hybrid-abridged procedure.
  • Changes in the Notice to Applicants regarding RDP, including the "reverse combination" principle.
  • The implications for pharmaceutical companies.

Meet the speakers

Emily MacKenzie
Brick Court Chambers

Barrister

Libby Amos
Associate

Email Disclaimer